Crashes and Violations Among Drivers With Alzheimer Disease

Trobe, Jonathan D.; Waller, P F; Cook-Flannagan, Carol; Teshima, Susan M.; Bieliauskas, Linas A.

doi:10.1001/archneur.1996.00550050033021

Cited by 166 publications

(99 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…These tests are poor predictors of future risk for crashes or violations. 46 Thus, neuropsychological assessment should be used only in conjunction with a standardized road evaluation.…”

Section: Methods Of Assessmentmentioning

confidence: 99%

“…45,46,[56][57][58] These studies may be confounded because of the failure to control for the amount of mileage actually driven, lack of control groups, small sample size, method of reporting and avoidance of high risk driving situations. [44][45][46]51,59 Overall, the evidence does support an increased risk of motor vehicle collisions in patients with dementia even with restrictions attached to driving, such as driving distance or location. 51,60-62…”

Section: Collision Ratementioning

confidence: 99%

See 1 more Smart Citation

Neurologic Conditions: Assessing Medical Fitness to Drive

Yale¹,

Hansotia²,

Knapp³

et al. 2003

Clinical Medicine & Research

View full text Add to dashboard Cite

Clinicians are often asked to make an assessment on whether a patient is medically fit to drive, even though few have been formally trained in this area. Driving is a complex task that requires having adequate operational, cognitive and higher executive functions that work together. These functions can be compromised to a greater or lesser extent in neurological disorders, such as stroke, traumatic brain injury, peripheral neuropathy, dementia, Parkinson's disease and epilepsy. There is insufficient standardized information relating to impaired function at this time. Because of this, state laws vary in their assessment of medical conditions as they relate to driver licensing. Wisconsin laws are reviewed as an example. There are numerous assessment tests for various functions, but they lack a validated correlation with actual driving performance. These and other factors, as well as practical recommendations for the practicing physicians, are the subjects of this review.

show abstract

“…These tests are poor predictors of future risk for crashes or violations. 46 Thus, neuropsychological assessment should be used only in conjunction with a standardized road evaluation.…”

Section: Methods Of Assessmentmentioning

confidence: 99%

Section: Collision Ratementioning

confidence: 99%

Neurologic Conditions: Assessing Medical Fitness to Drive

Yale¹,

Hansotia²,

Knapp³

et al. 2003

Clinical Medicine & Research

View full text Add to dashboard Cite

show abstract

“…Various researchers examined fitness to drive in persons with Alzheimer's disease [27,71,72], in subjects with different types of dementia [25,66], in patients with brain damage with or without aphasia [63], in TBI subjects [7,18,20,21,30], in mixed clinical population (typically TBI and cerebrovascular patients together) [11,16,28,29], or in normal subjects [60,73]. Obviously, findings in one population do not necessarily generalize to another.…”

Section: Introductionmentioning

confidence: 99%

Role of premorbid factors in predicting safe return to driving after severe TBI

Pietrapiana¹,

Tamietto

Torrini³

et al. 2005

Brain Injury

View full text Add to dashboard Cite

“…231 A diagnosis of dementia therefore does not automatically mean that a person is incapable of driving. 231,[235][236] The decision should be based on dementia severity or a demonstration of impaired driving competence. 231 4.…”

mentioning

confidence: 99%

Systematic review of recent dementia practice guidelines

2014

View full text Add to dashboard Cite

Level Type of Evidence + +High quality meta-analyses, systematic reviews of randomised controlled trials (RCTs), or RCTs with a very low risk of bias. +Well conducted meta-analyses, systematic reviews of RCTs, or RCTs with a low risk of bias. -Meta-analyses, systematic reviews of RCTs, or RCTs with a high risk of bias + +High quality systematic reviews of case control or cohort studies. High quality case control or cohort studies with a very low risk of confounding or bias and a high probability that the relationship is causal 2 + Well conducted case control or cohort studies with a low risk of confounding or bias and a moderate probability that the relationship is causal -Case control or cohort studies with a high risk of confounding or bias and a significant risk that the relationship is not causal 3Non-analytic studies, e.g. case reports, case series 4 Expert opinion Levels of evidence and grades of recommendation Statement of IntentThese guidelines are not intended to serve as a standard of medical care. Standards of medical care are determined on the basis of all clinical data available for an individual case and are subject to change as scientific knowledge advances and patterns of care evolve.The contents of this publication are guidelines to clinical practice, based on the best available evidence at the time of development. Adherence to these guidelines may not ensure a successful outcome in every case. These guidelines should neither be construed as including all proper methods of care, nor exclude other acceptable methods of care. Each physician is ultimately responsible for the management of his/her unique patient, in the light of the clinical data presented by the patient and the diagnostic and treatment options available. ForewordDementia represents a major public health concern in Singapore and worldwide. Being the most prevalent neurodegenerative disease, dementia is expected to affect 55,000 patients in Singapore by the year 2020. The commonest cause of dementia is Alzheimer's disease with vascular dementia being the next most important cause. Right from the stage of mild dementia up to the stages of severe dementia, this condition poses a significant health and socio-economic burden to patients, caregivers and the nation as a whole. Early diagnosis will allow appropriate use of pharmacological and non-pharmacological management. Along with disease stabilization, efforts to address caregiver burden, patient safety and medico legal concerns should form the principles of management. Clear practise guidelines will allow holistic and optimal care in dementia.I am pleased to present the revised clinical practise guidelines for dementia. In this regard the workgroup has performed a thorough review of the existing literature to recommend both pharmacological and nonpharmacological aspects of management for patients ranging from mild cognitive impairment to severe dementia. This revised guidelines also highlights issues related to the management of mild cognitive impairment, young onset dementia and e...

show abstract

Crashes and Violations Among Drivers With Alzheimer Disease

Cited by 166 publications

References 23 publications

Neurologic Conditions: Assessing Medical Fitness to Drive

Neurologic Conditions: Assessing Medical Fitness to Drive

Role of premorbid factors in predicting safe return to driving after severe TBI

Systematic review of recent dementia practice guidelines

Contact Info

Product

Resources

About